As an Amazon Associate, PauseAndFlourish earns from qualifying purchases.Product prices and availability are accurate as of the date reviewed.

Evidence-based menopause guidance

Know your stage.
Choose what actually helps.

Reviews, comparisons and a research library for every stage of perimenopause and menopause. Sorted by where you are, not by what sells.

62 products reviewed · 57 head-to-head comparisons · 179 cited studies

Editor's picks

All reviews
Youtheory Ashwagandha 1,000 mg
Editor's Pick

Youtheory Ashwagandha 1,000 mg

A high-potency 1,000 mg KSM-66 Ashwagandha supplement designed to support a healthy stress response and promote restful sleep during menopause.

Femmenessence MacaPause
Editor's Pick

Femmenessence MacaPause

A premium maca-based supplement, clinically studied for its ability to support the body's natural hormone balance for comprehensive menopause support.

Sports Research Collagen Peptides
Editor's Pick

Sports Research Collagen Peptides

Hydrolyzed Type I & III collagen powder supporting skin elasticity, hair, and joints during menopause.

STRIPES Evening Wear Retinol Night Cream vs. Olay Collagen Peptide Face Moisturizer

All 57 comparisons
Best forWomen experiencing accelerated skin aging, fine lines, and elasticity loss during menopause who want a gentle retinoid night creamWomen seeking a fragrance-free firming moisturizer for thinning, dry skin
Our score8.3/108.7/10
Editor's pickNoNo
CategoryMenopause SkincareMenopause Skincare

Olay is the simpler starting point for shoppers who want a fragrance-free, everyday firming moisturizer without adding a retinoid to the routine. STRIPES may suit shoppers who specifically want a retinoid-based night cream and are comfortable with the premium price and the fragrance the committed record lists. Neither replaces sun protection or individualized skincare guidance.

A retinoid night cream built around menopause skin changes versus a fragrance-free peptide and niacinamide moisturizer

Read the full comparison

Every recommendation cites its source

Research library
Cross-Sectional

Early Perimenopause Symptoms Can Appear Before Hot Flashes

In this cross-sectional analysis of Australian women without vasomotor symptoms, early perimenopause was defined by a menstrual-cycle variation of at least 7 days, and its symptom profile differed little from the late reproductive stage with changed flow. The findings indicate that changed flow alone is not a clear marker of transition onset and cannot establish that a particular symptom was caused by menopause.

Bresolin S, Islam RM, Bond M, Davis SR. Symptom profiles in the late reproductive stage, earlier premenopause and early perimenopause in the absence of vasomotor symptoms: a cross-sectional study. BMJ Sex Reprod Health. 2026;52(3):192-199. doi:10.1136/bmjsrh-2025-203075. PMID: 41813093.

Cross-Sectional

Hot Flashes Become More Common in Late Perimenopause

Among 8,096 Australian participants, moderately-to-severely bothersome hot flashes increased from 8.8% in premenopause to 37.3% in late perimenopause, while vaginal dryness also became more discriminative across the transition. This cross-sectional result describes prevalence at one point in time, so it does not establish a single cause for an individual's symptoms.

Islam RM, Bond M, Ghalebeigi A, Wang Y, Walker-Bone K, Davis SR. Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women's Midlife Years (AMY) Study. Lancet Diabetes Endocrinol. 2025;13(9):765-776. doi:10.1016/S2213-8587(25)00138-X. PMID: 40720963.

RCT

Digital CBT Reduced Hot-Flash Burden in a Pilot Trial

In an open-label pilot randomized trial of 100 participants with bothersome vasomotor symptoms, a self-guided digital cognitive behavioral therapy app added to usual care improved hot-flash problem ratings over 12 weeks versus usual care alone. Because the trial was small, open label, and relied on self-reported outcomes, larger confirmatory studies are still needed.

Stute P, Pavicic E, Schulze-Wundling K, Kutsojannis H, Green SM, Theis S. Effectiveness of a digital cognitive behavioral therapy application for vasomotor symptoms in menopausal women: An open-label pilot randomized controlled trial. Maturitas. 2026;213:109090. doi:10.1016/j.maturitas.2026.109090. PMID: 42641440.

Join the Community

Evidence-Based Menopause Guidance
Delivered Every Monday

Join thousands of women who receive our latest product reviews, clinical research summaries, and stage-specific wellness tips every week.

No spam, ever. Unsubscribe at any time. By subscribing, you agree to our Privacy Policy.